跳至主要内容
临床试验/ACTRN12618001349235
ACTRN12618001349235尚未招募4 期

Efficacy and safety of Artesunate-mefloquine with low dose primaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Champasack province, Lao PDR

Ministry of Health0 个研究点目标入组 120 人开始时间: 2018年8月9日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 Months 至 —(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验

暂停
4 期
Efficacy and safety of artesunate-mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Binh Phuoc and Dak Nong provinces, Viet Nam, in 2019.Patients infected Plasmodium falciparum malaria.Infection - Other infectious diseases
ACTRN12620001375943World Health Organization84
尚未招募
4 期
Efficacy and safety of artesunate+mefloquine+primaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Tak, Ratchaburi, Ranong and Yala provinces in Thailandncomplicated falciparum malaria patientsUncomplicated falciparum malaria patientsInfection - Other infectious diseases
ACTRN12610000553077Bureau of Vector-borne Disease300
尚未招募
4 期
Efficacy and safety of artesunate+mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mae Hong Son, Kanchanaburi, Ubonratchathani and Surin provinces in Thailandncomplicated falciparum malaria patientsUncomplicated falciparum malaria patientsInfection - Other infectious diseases
ACTRN12611000521921Bureau of Vector-Borne Disease200
尚未招募
4 期
Safety and efficacy of artesunate-amodiaquine for the treatment of uncomplicated malaria in BurundiMalaria
PACTR201905610589889Ministere de la Sante Publique352
已完成
4 期
Efficacy and safety of artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in West Sumba District, East Nusatenggara Province, IndonesiaInfection - Studies of infection and infectious agentsMalaria
ACTRN12611000999932Malaria sub-directorate, Directorate General of Disease control and Environmental Sanitation100